期刊文献+

网络嵌入性与技术创新:间接联系及联盟多样性如何影响企业技术创新 被引量:17

Network Embeddedness and Technological Innovation: How Indirect Ties and Diversity of Alliance Types Affect Technological Innovation?
原文传递
导出
摘要 关注战略联盟网络中,间接联盟关系及联盟类型多样性对技术创新数量和质量是否存在差异化影响。以网络理论和技术创新理论为基础,基于USPTO专利数据库、Recap联盟数据库和Compustat上市企业数据库,使用泊松回归对假设进行验证,研究发现:企业间接联系增加仅对创新质量有负向影响;企业联盟类型多样性增加对创新数量和创新质量都具有正向影响。 This study focuses on how indirect alliance partners and diversity of alliance types affect innovation quantity and quality. This study is based on theory of network and technological innovation, and panel data of bio- technology and pharmaceutical industry from 1990 to 2001 based on USPTO patent database, Recap alliance da- tabase and Compustat database. Then this study uses Poisson regression model to test hypotheses. Here are the main conclusions: a, the increase of indirect ties has a negative impact on innovation quality; b,the increase of diversity of alliance types has a positive impact on innovation quantity and quality
作者 杨张博 YANG Zhangbo(School of Social Science and Humanities,Xi'an Jiaotong University,Xi'an 710049,China;Institute for Empirical Social Science Research,Xi'an Jiaotong University,Xi'an 710049,China)
出处 《科学学与科学技术管理》 CSSCI CSCD 北大核心 2018年第7期51-64,共14页 Science of Science and Management of S.& T.
基金 中国博士后科学基金(2016M602791) 陕西省软科学项目(2017KRM118) 陕西省博士后科学基金(2017BSHEDZZ131) 西安交通大学基本科研业务费(SK2018030)
关键词 技术创新 战略联盟 战略网络 technological innovation strategic alliance strategic network
  • 相关文献

参考文献2

二级参考文献33

  • 1国务院.生物产业发展规划[OL].http://www.gov.cn/zwgk/2013-01/06/content_2305639.htm,2013-01-06.
  • 2PhRMA. Medicines in development-Biologics [ R ]. America's Biopharmaceutical Research Companies,2013.
  • 3DIMXSI J A, GRABOWSKI H G.. The cost of biopharma- ceutical R&D : is biotech different? [ J ]. Managerial and Deci- sion Economics, 2007,28:469-479.
  • 4JAE K R,HYO S K,DOO H N. Current status and per- spectives of biopharmaceutical drugs [ J ]. Biotechnology and Bioprocess Engineering,2012,17:900-911.
  • 5工业和信息化部.医药工业“十二五”发展规划[OL]http://www.gov.cn/gzdt/2012-01/19/content_2049023htm,2012-01-19.
  • 6Contract Pharma. Top 10 biopharmaceutical companies [ OL ]. http://www, contractpharma, com/heaps/view/68, 2012-07-19.
  • 7Contract Pharma. Top 50 ( or so ) biopharma products [ OL ]. http://www, contractpharma, com/issues/2012-07/ view_features/top-50-or-so-biopharma-products/, 2012 -07-18.
  • 8ERNST&YOUNG. Beyond borders : biotechnology indus- try report 2013 [ OL]. http://www, ey. com/beyondborders, 2013-09-01.
  • 9OWEN-SMITH J, POWELL W W. Knowledge networks as channels and conduits : the effects of spillovers in the Boston biotechnology community [ J ]. Organization Science, 2004,15 : 5-21.
  • 10MULLARD A. Maturing antibody - drug conjugate pipe- line hits 30 [ J ]. Nature Reviews Drug Discovery, 2013,5 (12) :329-332.

共引文献32

同被引文献225

引证文献17

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部